Artal Group S.A. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 124 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$3,668,000
-16.3%
35,0000.0%0.15%
-17.3%
Q1 2019$4,384,000
-44.4%
35,000
-50.0%
0.18%
-38.7%
Q4 2018$7,890,000
-26.3%
70,000
+40.0%
0.29%
+4.7%
Q3 2018$10,707,000
-23.4%
50,0000.0%0.28%
-6.1%
Q2 2018$13,985,000
+166.1%
50,000
+11.1%
0.30%
+350.0%
Q1 2018$5,256,00045,0000.07%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders